National and Kapodistrian University of Athens
Επανεργοποίηση της έκφρασης της εμβρυϊκής αιμοσφαιρίνης με χημικές ουσίες σε in vitro και in vivo πειραματικά συστήματα
Abstract
dc:descriptionThalassaemia is one of the most common hereditary blood diseases resulting from reduced or absent production of one or more of the globin chains. The main experimental approaches for finding a cure are gene therapy and pharmacological reactivation of the gamma-globin gene which results in the production of foetal haemoglobin (HbF). This thesis is involved with the latter therapeutic approach.The principal aim of this work was to identify substances that induce the expression of the gamma-globin gene which is responsible for production of the gamma globin chain of foetal haemoglobin. The choice of substances to be studied was based either on their mechanism of action or on their chemical structure. All substances were initially studied in vitro in the GM979 cell system. Substances that had a positive activity in GM979 cells were subsequently studied ex vivo in cultures of erythroblast cells derived from healthy donors and thalassaemia patients. Substances of particular interest were then studied in vivo in transgenic mice. For the targeted synthesis of new derivatives with improved activity, a QSAR (Quantitative structure-activity relationship)software model was developed to processes the results of the screening of substances in GM979 cells and make predictions about changes in structure which can potentially improve their action. To study the molecular mechanism of action of HbF-inducing substances, chromatin immunoprecipitation (ChIP) experiments were employed.In the first part of the project 65 test substances were selected. These substances were classified into six different categories according to the main molecular mechanism of action: substances (and their derivatives) that cause hypomethylation, inhibitors of histone deacetylation, compounds that bind to DNA, anthracyclines, inhibitors of ribonucleotide reductase and substances which are antioxidants, metabolites or drugs that affect metabolic pathways. In summary, of the 65 substances studied, 13 were active in the GM979 cell system. Of those 13 positive substances, eight were active in BFUe cells from healthy individuals. Six out of these eight substances were also active in BFUe cells from thalassaemic donors. Importantly, these substances had even higher activity in some of the patient cultures than hydroxyurea. The six substances are: oxamflatin, 5-fluoro2'deoxyuridine, diammine-dinitritoplatinum, daunorubicin, idarubicin and 3,3 '5-triodo-L-Thryonine. Daunorubicin was selected for further screening in transgenic mice where it caused a significant increase in gamma-globin mRNA, gamma-globin chains and the number of F cells. Further studies on the mechanism of action of these compounds will shed more light on their suitability as potential pharmacological agents for the treatment of β-thalassaemia while screening of more derivatives of these drugs will help in identifying more effective drugs.Studies of the mechanism of action of mithramycin and oxamflatin showed that mithramycin causes a reduction in the binding of transcription factor Sp1 to selected regulatory regions of the Locus Control Region (LCR) and that oxamflatin causes an increase in the acetylation of regulatory regions in the γ-globin gene and the LCR.Chemical modification and synthesis of derivatives of MS-275, one of the active substances tested, was carried out as part of this project in combination with the virtual screening of the synthetic derivatives using a QSAR model aiming to improve the action and reduce the cytotoxicity of test substances. 26 new derivatives were chemically synthesised. Only one of the newly synthesised chemical derivatives, CRC144, was both non-toxic and had comparable activity to MS275 at the same concentration.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spyrou, Pandelis
- Σπύρου, Παντελής
Subjects
dc:subject × 20- Εμβρυακή αιμοσφαιρίνη
- Ανθρακυκλίνες
- Καταστολείς της αποακετυλάσης των ιστόνων
- Βλαστικά κύτταρα της ερυθράς σειράς
- Διαγωνιδιακά ποντίκια
- Σύνθεση χημικών παραγώγων
- Εικονικός έλεγχος
- Ανοσοκατακρήμνιση
- Fetal haemoglobin
- Anthracyclines
- Histone deacetylase inhibitors
- Burst forming units erythroid
- Transgenic mice
- Chemical compound synthesis
- In silico screening
- Chromatin immunoprecipitation (ChIP)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29678